Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix Primary and Booster Vaccination in Japanese Children
NCT01027845Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2009
- Primary completion
- Aug 2010
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection (2 arms), sponsored by GSK. Primary endpoint: Concentrations of Antibodies Against Vaccine Pneumococcal Serotypes. Started Dec 2009; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01027845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01027845.